Jan Adams has been appointed as the Chief Scientific Officer at Grünenthal, succeeding Janneke van der Kamp who will be leaving the company. With over two decades of experience in the pharmaceutical and healthcare industry, Jan has been instrumental in driving Grünenthal's transformational journey and building a state-of-the-art R&D organization.